Cushman & Wakefield Ltd SEC Filings

Cushman & Wakefield plc is being removed from listing and registration on the New York Stock Exchange for its common shares under Section 12(b) of the Securities Exchange Act of 1934. The notification, filed on Form 25 by the exchange, states that the NYSE has complied with its own rules and the requirements of 17 CFR 240.12d2-2(b) to strike the common shares from listing and/or registration. It also notes that the issuer has complied with the exchange’s rules and 17 CFR 240.12d2-2(c) regarding voluntary withdrawal of the common shares from listing and registration. After this process is completed, Cushman & Wakefield’s common shares will no longer trade on the NYSE, which typically means investors must use another market or mechanism to buy or sell the stock.

Cushman & Wakefield (CWK) reported stronger Q3 results. Revenue rose to $2,605.9 million from $2,344.2 million, and operating income increased to $107.5 million from $75.2 million. Net income was $51.4 million, or $0.22 per diluted share, up from $0.14. Adjusted EBITDA reached $159.6 million versus $142.5 million. Year to date, revenue was $7,374.4 million and Adjusted EBITDA was $417.5 million.

The company continued to de‑risk its balance sheet. Long‑term debt, net, declined to $2,720.1 million from $2,939.6 million, reflecting $200.0 million of 2025 prepayments on term loans and spread reductions to 1‑month SOFR plus 2.75% on both 2030 tranches. Interest expense year to date decreased to $161.5 million from $174.4 million. Cash and cash equivalents were $634.4 million; the $1.1 billion revolver was undrawn. Segment revenue in Q3 was led by the Americas at $1,923.1 million, with EMEA at $260.1 million and APAC at $422.7 million. As of October 24, 2025, 231,604,548 ordinary shares were outstanding.

Cushman & Wakefield (CWK) furnished an 8‑K to announce it issued a press release reporting financial results for the third quarter of 2025. The release is included as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).

The company noted that the information in Item 2.02, including Exhibit 99.1, is furnished, not filed under the Exchange Act, which means it is not subject to Section 18 liability and is not incorporated by reference unless specifically stated.

Vaughan Nelson Investment Management filed an amended Schedule 13G reporting beneficial ownership of 10,320,243 shares of Cushman & Wakefield plc (CWK), representing 4.46% of the class as of 09/30/2025.

The filer reports sole voting power over 8,951,434 shares and sole dispositive power over 9,397,534 shares, with shared dispositive power over 922,709 shares and no shared voting power. The position is held in the ordinary course, and the filing states it was not made for the purpose of changing or influencing control.

Vaughan Nelson notes various investment advisory clients may receive dividends or sale proceeds tied to these shares, and to its knowledge no single such person has more than 5% of the issuer’s outstanding common stock.

Cushman & Wakefield plc amended its senior credit facility effective October 21, 2025. The Amendment reduces the revolving commitments from $1,100 million to $1,000 million and extends the revolving maturity from April 28, 2027 to October 21, 2030, subject to a springing maturity date in certain circumstances.

The update also refreshes currency reference rates for revolving borrowings, including replacing CDOR with Term CORRA, and reduces applicable interest for certain levels within the leverage-based pricing step downs as set forth in the Credit Agreement. A press release describing the Amendment was furnished as Exhibit 99.1, and the full Amendment was filed as Exhibit 10.1.

Cushman & Wakefield (CWK) shareholders approved a plan to redomicile from England and Wales to Bermuda via a court‑sanctioned scheme of arrangement. Resolutions at the Court Meeting and General Meeting—each requiring at least 75% approval—were passed, paving the way for the transaction, including a one‑for‑one issuance of common shares of Cushman & Wakefield Ltd. to existing holders.

Shareholder participation was high at each meeting, and advisory votes on proposed bye‑law changes were also approved. The closing remains subject to Court sanction and other conditions. The proposed timeline lists a Court hearing on November 25, 2025; record time and last trading/disablement at 5:00 p.m. ET on November 26, 2025; effectiveness and cancellation/issuance on November 27, 2025; and listing and trading of the new shares at market open on November 28, 2025.

Cushman & Wakefield plc (CWK) director Stephen D. Plavin filed an initial Form 3 reporting his relationship to the issuer as a Director. The filing shows the reporting event date as 10/01/2025 and lists Mr. Plavin's address in Chicago, IL. The Form 3 discloses 0 Ordinary Shares beneficially owned (direct ownership) at the time of the filing and is signed on behalf of the reporting person on 10/02/2025.

Cushman & Wakefield plc reported a material event filing that documents an Amendment No. 12 to its Credit Agreement dated October 1, 2025. The amendment names Cushman & Wakefield U.S. Borrower, LLC and DTZ UK Guarantor Limited among the obligors and lists JPMorgan Chase Bank, N.A. as administrative agent and other lenders as parties to the agreement.

The company also issued a related press release dated October 2, 2025, and provided an interactive Inline XBRL cover page. The filing is signed by Neil Johnston, Chief Financial Officer. The document itself lists the amendment and the press release as the disclosed material events without additional financial details or explanatory text.

No amounts, covenants, financial impacts, or forward-looking statements are provided in the disclosed text, so the filing communicates the existence and timing of the amendment and press release but does not describe their substantive effects.

Cushman & Wakefield plc (CWK) director Angela Sun sold 6,800 ordinary shares on 09/05/2025 at $16.02 per share, reducing her beneficial holdings to 46,498 shares. The filing is a routine Section 16 Form 4 disclosing an insider sale processed by an attorney-in-fact and signed on 09/09/2025. The record shows the transaction type as a direct disposition and provides the exact price and post-transaction holdings.